Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyPsoriasisTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyPsoriasisTeam Member asked a question 💭
Kalamazoo, MI

I was diagnosed with psoriasis in my hands and my dermatologist prescribed icotyde.

2 days ago
 · 
Reactions
A MyPsoriasisTeam Member

👋🏻Hi Kim, a very warm welcome to our community!🤗 To answer your question: yes, members are definitely starting to discuss Icotyde (icotrokinra). It is a brand-new, first-of-its-kind oral systemic tablet approved by the FDA in 2026 for moderate-to-severe plaque psoriasis in adults and adolescents aged 12 and up. What makes it unique is that it is a daily pill that targets the IL-23 receptor pathway—a pathway previously only targeted by biologic injections like Skyrizi or Tremfya. Clinical trials showed it can provide significant skin clearance, even in hard-to-treat areas. Make sure to double-check the physical label and consult your dermatologist to confirm if this treatment matches your specific health profile, as it requires a prescription and careful evaluation of potential side effects or infections. We're so glad you've joined us to explore these new options!🥳

1 day ago
MyPsoriasisTeam

Icotyde (icotrokinra) is a newer once-daily pill approved by the FDA in March 2026 for moderate to severe plaque psoriasis in adults and teens 12 and older. Since it's quite new, firsthand community experiences are still building up — but the clinical trial results are pretty encouraging!

Here's what the studies showed:

- Show Full Answer

Icotyde (icotrokinra) is a newer once-daily pill approved by the FDA in March 2026 for moderate to severe plaque psoriasis in adults and teens 12 and older. Since it's quite new, firsthand community experiences are still building up — but the clinical trial results are pretty encouraging!

Here's what the studies showed:

- Around 65–71% of people had clear or almost clear skin by week 16
- 50–58% reached at least 90% improvement in their psoriasis (PASI 90) by week 16
- Some people noticed itch improvement as early as week 4
- By week 52, about 84% of those who stayed on it maintained their results Icotyde works by blocking the IL-23 receptor, which helps calm the overactive immune response behind plaque buildup and skin inflammation. It's taken on an empty stomach first thing in the morning, with at least a 30-minute wait before eating. If swallowing tablets is tricky, it can be dissolved in water. Like any medication, there are some things to be aware of. The most commonly reported side effects include:

- Headache
- Nausea
- Cough
- Fatigue
- Fungal infections (like athlete's foot or oral thrush)

More seriously, Icotyde can lower your ability to fight infections, so it's important to tell your doctor right away if you notice signs like fever, chills, or unusual skin sores. Your doctor may also check for tuberculosis (TB) before starting treatment. If cost is a concern, Johnson & Johnson offers a savings program where eligible people with commercial insurance may pay as little as $0 per month. It's worth calling (Phone number can only be seen by the question and answer creators) or checking the Icotyde withMe Savings Program website for details.

As always, your dermatologist is the best person to guide you through what to expect — and it sounds like they're already on top of it!

2 days ago

Related Questions

View All
A MyPsoriasisTeam Member asked a question 💭
Lecanto, FL

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In